-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Traws Pharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2024.
- Traws Pharma, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$5.28M, a 18.3% decline year-over-year.
- Traws Pharma, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$142M, a 601% decline year-over-year.
- Traws Pharma, Inc. annual Operating Income (Loss) for 2024 was -$142M, a 601% decline from 2023.
- Traws Pharma, Inc. annual Operating Income (Loss) for 2023 was -$20.3M, a 3.42% decline from 2022.
- Traws Pharma, Inc. annual Operating Income (Loss) for 2022 was -$19.6M, a 19% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)